Summary
- Current Price
- As of today, NTRA price is $267.76, down -0.70% on
- Current Price All-Time High
- NTRA price is currently -7.04% below its historical high of $288.04 set on
- Market Cap
- NTRA current market cap is $38B, up +109.79% over the past 365 days
- Revenue
- NTRA current annual revenue is $2.31B, up +35.90% year-over-year
- Next Earnings
- The next earnings release for NTRA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Natera, Inc. |
| Ticker | NASDAQ: NTRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | natera.com |
| Employees | 4,424 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $267.76 | |
| Price, 1D Change | -0.70% | |
| Market Cap | $38B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.18 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +35.90% | |
| EPS | -$1.52 | |
| EPS, 1Y Change | +0.28% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.52 | |
| EPS Estimate | N/A | -$1.71 |
| EPS Est. Change | N/A | -12.24% |
| Revenue | $2.31B | |
| Revenue Estimate | N/A | $2.80B |
| Revenue Est. Change | N/A | +21.29% |
| Current Price | $267.76 | |
| Price Target | - | $290.00 |
| Price Tgt. Change | - | +8.31% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.55 | -$1.53 | +1.51% | |
| -$2.42 | -$1.52 | +37.06% | |
| -$1.71 | N/A | -12.24% | |
| -$0.20 | N/A | +86.56% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.63B | $1.70B | +3.98% | |
| $2.24B | $2.31B | +3.04% | |
| $2.80B | N/A | +21.29% | |
| $3.33B | N/A | +44.32% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +100.33% | |
| Price, 3Y | +492.13% | |
| Market Cap, 1Y | +109.79% | |
| Market Cap, 3Y | +643.54% | |
| Revenue, 1Y | +35.90% | |
| Revenue, 3Y | +181.16% | |
| EPS, 1Y | +0.28% | |
| EPS, 3Y | +72.65% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $267.76 | |
| SMA 200 | $220.57 | |
| SMA 50 | $244.72 | |
| EMA 200 | $217.49 | |
| EMA 50 | $248.92 | |
| MACD | $3.55 | |
| Beta | 1.18 | |
| ATR | $11.49 | |
| 14-Day RSI | 55.94 | |
| 10-Day Volatility | 41.93% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.31B | |
| EPS | -$1.52 | |
| Gross Profit | $0.00 | |
| Gross Margin | 64.67% | |
| Operating Income | -$306.01M | |
| Operating Margin | -13.27% | |
| Net Income | -$208.16M | |
| Net Margin | -9.03% | |
| EBITDA | -$262.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.13 | |
| 3.39 | ||
| 3.24 | ||
| - | ||
| 4 | ||
| 28.79 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 15.33 | ||
| 21.62 | ||
| -141.04 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.71B | |
| $1.08B | ||
| $2.51B | ||
| $1.50B | ||
| $795.62M | ||
| $441.23M | ||
| Total Debt | $214.38M | |
| $95.90M | ||
| $33.16M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $2.51B | ||
| $1.80B | ||
| $814.65M | ||
| $1.18B | ||
| $43.48M | ||
| $0.00 | ||
| -$59.93M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $215.30M | ||
| -$132.21M | ||
| $47.46M | ||
| Capex | $139.19M | |
| $76.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Morgan Stanley | → | |
| Evercore ISI Group | → | |
| Guggenheim | → | |
| Bernstein | ||
| BTIG | → | |
| Barclays | → | |
| BTIG | → | |
| Goldman Sachs | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with NTRA
FAQ
- What is the ticker symbol for Natera, Inc.?
- The ticker symbol for Natera, Inc. is NASDAQ:NTRA
- Does Natera, Inc. pay dividends?
- No, Natera, Inc. does not pay dividends
- What sector is Natera, Inc. in?
- Natera, Inc. is in the Healthcare sector
- What industry is Natera, Inc. in?
- Natera, Inc. is in the Diagnostics & Research industry
- What country is Natera, Inc. based in?
- Natera, Inc. is headquartered in United States
- When did Natera, Inc. go public?
- Natera, Inc. initial public offering (IPO) was on July 1, 2015
- Is Natera, Inc. in the S&P 500?
- No, Natera, Inc. is not included in the S&P 500 index
- Is Natera, Inc. in the NASDAQ 100?
- No, Natera, Inc. is not included in the NASDAQ 100 index
- Is Natera, Inc. in the Dow Jones?
- No, Natera, Inc. is not included in the Dow Jones index
- When was Natera, Inc. last earnings report?
- Natera, Inc.'s most recent earnings report was on May 7, 2026
- When does Natera, Inc. report earnings?
- The next expected earnings date for Natera, Inc. is August 6, 2026
Data Sources & References
- NTRA Official Website www.natera.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1604821/000110465926020881/0001104659-26-020881-index.htm
- NTRA Profile on Yahoo Finance finance.yahoo.com/quote/NTRA
- NTRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ntra
